Get started
simbha

One more push above 33... Kaboom!

Long
Exelixis, Inc. (NASDAQ:EXEL)  
simbha  
NASDAQ:EXEL   Exelixis, Inc.
Fibonacci
4
0
fibonacci
Consistently performed in FDA approvals for last 2 years.
Last push above 33 sometime this year with accelerating revenues growth... TA roadmap is set.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.